{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/how-fortrea-mobile-clinical-services-mcs-may-improve-patient-experience-oncology-studies#webpage",
"url": "https://www.fortrea.com/insights/how-fortrea-mobile-clinical-services-mcs-may-improve-patient-experience-oncology-studies",
"name": "How Fortrea Mobile Clinical Services (MCS) may improve the patient experience in oncology studies",
"description": "This Fortrea case study explores how Mobile Clinical Services (MCS) improved the patient experience in oncology studies through decentralized and patient-centric clinical trial support models. Oncology clinical trials often create significant logistical and physical burdens for patients undergoing intensive treatment, making patient engagement and retention increasingly challenging. The case study highlights how Fortrea Mobile Clinical Services supported global Phase I, II, and III oncology trials by enabling home-based clinical activities, including biological sample collection, investigational product administration, vital sign assessments, questionnaire review, and remote patient support. By integrating decentralized clinical trial solutions with flexible site support, the approach reduced patient burden, improved accessibility, and strengthened patient retention across complex oncology programs. This Fortrea case study demonstrates how mobile clinical services, decentralized operational strategies, and patient-focused trial execution can improve the oncology study experience while supporting efficient clinical trial delivery and high-quality data collection"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "How Fortrea Mobile Clinical Services (MCS) may improve the patient experience in oncology studies",
"item": "https://www.fortrea.com/insights/how-fortrea-mobile-clinical-services-mcs-may-improve-patient-experience-oncology-studies"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/how-fortrea-mobile-clinical-services-mcs-may-improve-patient-experience-oncology-studies#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/how-fortrea-mobile-clinical-services-mcs-may-improve-patient-experience-oncology-studies#webpage"
},
"headline": "Mobile Clinical Services in Oncology Trials to Improve Patient Experience | Fortrea Case Study",
"description": "This Fortrea case study explores how Mobile Clinical Services (MCS) improved the patient experience in oncology studies through decentralized and patient-centric clinical trial support models. Oncology clinical trials often create significant logistical and physical burdens for patients undergoing intensive treatment, making patient engagement and retention increasingly challenging. The case study highlights how Fortrea Mobile Clinical Services supported global Phase I, II, and III oncology trials by enabling home-based clinical activities, including biological sample collection, investigational product administration, vital sign assessments, questionnaire review, and remote patient support. By integrating decentralized clinical trial solutions with flexible site support, the approach reduced patient burden, improved accessibility, and strengthened patient retention across complex oncology programs. This Fortrea case study demonstrates how mobile clinical services, decentralized operational strategies, and patient-focused trial execution can improve the oncology study experience while supporting efficient clinical trial delivery and high-quality data collection",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/mcs-may-improve-the-patient-experienc-in-oncology-studies.pdf",
"encodingFormat": "application/pdf"
}
}
]
}